Clinical Trial Update: Vaccine Therapy Using Melanoma Peptides for Cytotoxic T Cells and Helper T Cells in Treating Patients With Metastatic Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating vaccine therapy using melanoma peptides to stimulate cytotoxic and helper T cells in metastatic melanoma; completed with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• Melanoma Peptide Vaccine (melanoma peptide vaccine)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Melanoma (Skin) | Phase 2 | Status: COMPLETED | Results posted: 2013-01-03